A phase I clinical trial of 3D-pluripotent stem cell biologics in heavily treated advanced NSCLC patients.
CANCER RESEARCH（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined